Navigation Links
Acne Scars Significantly Improved by a Combination Treatment of Photodynamic Therapy and Percutaneous Collagen Induction

PHOENIX, Oct. 4 /PRNewswire/ -- The appearance of facial acne scars showed greater improvement with a combination treatment of photodynamic therapy (PDT) and percutaneous collagen induction (PCI or medical needling) with the ENVIRON® Surgical Roll-CIT(TM) compared to PDT alone.

The results of the pilot split-face comparison were presented by Hilton Kaplan, MD PhD, Medical Advisor for ENVIRON® distributor DermoGenesis, at the 2009 Joint Annual Meeting of the American Society of Dermatologic Surgery (ASDS) and American Society of Cosmetic Dermatology & Aesthetic Surgery (ASCDAS).

"Facial acne scars are disfiguring and medically challenging to treat," noted Julie Kenner, MD PhD, the study's lead author and a dermatologist in Kailua, Hawaii. "Combining PDT and medical needling offers an effective new treatment for acne scarring that is suitable for all skin types and regions because it does not strip or remove the epidermis."

PDT uses photosensitive chemicals activated by light to treat targeted areas of acne scarring. Medical needling with the ENVIRON® Surgical Roll-CIT(TM) improves scarring by creating micro-clefts in the skin, which initiates a platelet-driven healing cascade that results in regenerative forms of collagen and elastin.

After three treatments, the side treated with PDT and PCI showed an average increase in Type I collagen and epidermal thickness that was, respectively, 5.46 and 10.5 times greater than the side treated with PDT alone. Results were verified by comparing clinical photographs and histological samples obtained prior to and after the treatments.

Four subjects with facial acne scarring and Fitzpatrick skin types II to IV were included in the pilot study. During the treatment, medical needling was performed on the right cheek of each subject. Then, 5-aminolevinic acid (ALA) was applied to both cheeks and activated by IPL (400-700nm). Sunscreen and ENVIRON® topical products containing fat forms of vitamins A and C were used daily throughout.

For more information, please visit or email

About ENVIRON and DermoGenesis

ENVIRON offers a complete and synergistic system of skin care products and medical-needling devices that is available only through medical doctors and ENVIRON-trained professionals. DermoGenesis is a distributor of ENVIRON in the United States.

SOURCE DermoGenesis

SOURCE DermoGenesis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant
2. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
3. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
7. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
8. Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
9. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
10. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
11. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Today AVACEN Medical announced the issue of United ... Energy Including Blood Viscosity Adjustment ". This patent shields the company,s AVACEN 100 dry heat therapy ... Method. Photo - ... ... ...
(Date:11/25/2015)... Endo International plc (NASDAQ: ENDP ) (TSX: ENL) today ... will discuss corporate updates at the 27 th Annual ... on Wednesday, December 2, 2015 at 1 p.m. ET. ... then the link to the event. Participants should allow approximately ... the site and download any streaming media software needed to ...
(Date:11/25/2015)... NEW YORK , November 25, 2015 ... global market of self-monitoring blood glucose devices was valued ... to grow with a CAGR of 5.7% during 2015 ... increasing geriatric population and increasing prevalence of diabetes. In ... about diabetes care is also contributing to the growth ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... As ... Water For Empowerment ™ attracts volunteers together who want to combine talents and ... as key stakeholders in the process. The non-profit launched its first major fundraiser ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless ... treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, ... without the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro ...
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, a Jacksonville-based drug ... their sobriety and show through pictures what a positive difference it makes. The ... with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short ...
(Date:11/25/2015)... ... ... On November 23rd 2015 Cozy Products, a division of Bird-X ... Products explains what this means for business moving forward. , The Tri Lite heater ... model: to sell personal heaters that reduce energy consumption, are economical and keep people ...
(Date:11/25/2015)... ... 2015 , ... In an ongoing Clinical Study conducted by an independent physician, ... Angel is evaluating the efficacy of its product and its disinfection protocol. This study ... from May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located ...
Breaking Medicine News(10 mins):